These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 6164240)

  • 1. Chemical modification and antigenicity of glioma cells.
    Stavrou D; Hultén M; Bilzer T
    Acta Neuropathol Suppl; 1981; 7():75-8. PubMed ID: 6164240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The humoral antibody response of rats immunized with chemically modified syngeneic brain cells and glioma cells.
    Stavrou D; Hultén M; Anzil AP; Bilzer T
    Int J Cancer; 1980 Nov; 26(5):629-37. PubMed ID: 7239719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of various chemicals on the surface structure and the antigenicity of syngeneic glioma cells.
    Zänker KS; Stavrou D; Hultén M; Bilzer T
    Anticancer Res; 1981; 1(2):101-7. PubMed ID: 7347153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor specific fluorescent and complement-dependent cytotoxic antibodies in the serum of rats with chemically induced brain gliomas.
    Stavrou D; Anzil AP; Elling H
    Acta Neuropathol; 1978 Aug; 43(1-2):111-7. PubMed ID: 676675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reactivity of tumor-infiltrating, blood, spleen and lymph node lymphocytes against syngeneic glioma target cells.
    Stavrou D; Bilzer T; Anzil AP; Hultén M; Kaldrymidou E
    Anticancer Res; 1981; 1(3):125-34. PubMed ID: 7342850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoclonal antibodies reactive with glioma cell lines derived from experimental brain tumors.
    Stavrou D; Süss C; Bilzer T; Kummer U; De Tribolet N
    Eur J Cancer Clin Oncol; 1983 Oct; 19(10):1439-49. PubMed ID: 6196200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologic analysis of nitrosourea-induced rat gliomas.
    Pfreundschuh M; Cravioto H; Hochwald G; Ransohoff J
    J Natl Cancer Inst; 1982 Mar; 68(3):501-5. PubMed ID: 6950179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antigenicity of a chemically induced neurogenic rat sarcoma (author's transl)].
    Elling H; Stavrou D
    Vet Pathol; 1980 Jul; 17(4):477-89. PubMed ID: 6155730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of ethylnitrosourea-induced rat gliomas for the presence of tumour rejection antigens expressed in vivo.
    Spence AM; Priestley G
    Neuropathol Appl Neurobiol; 1981; 7(1):63-75. PubMed ID: 7231638
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunization against ethylnitrosourea-induced autochthonous neurogenic rat tumours.
    Spence AM; Hellström KE; Hellström I; Van Belle G; Sullivan K; Wahlström T
    Br J Cancer; 1979 Jul; 40(1):164-7. PubMed ID: 454562
    [No Abstract]   [Full Text] [Related]  

  • 11. Generation of cellular immune responses against a glioma-associated antigen(s).
    Holladay FP; Wood GW
    J Neuroimmunol; 1993 Apr; 44(1):27-32. PubMed ID: 8496337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Brain tumors in the rat induced by methylnitrosourea (induction, transplantation, monolayer cultivation)].
    Zhmareva EN; Verkhogliadova TP
    Zh Vopr Neirokhir Im N N Burdenko; 1983; (2):52-9. PubMed ID: 6868903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of tumor cells modified by trinitrobenzene suflonic acid (TNBS).
    Kedar E; Unger E; Galili N; Klein G; Asjo B; Bonavida B; Naor D
    Prog Clin Biol Res; 1976; 9():109-21. PubMed ID: 1030796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of cytotoxic immune responses against a rat glioma by in vivo priming and secondary in vitro stimulation with tumor cells.
    Holladay FP; Lopez G; De M; Morantz RA; Wood GW
    Neurosurgery; 1992 Apr; 30(4):499-504; discussion 504-5. PubMed ID: 1584347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic vaccination against malignant gliomas based on allorecognition and syngeneic tumor antigens: proof of principle in two strains of rat.
    Stathopoulos A; Samuelson C; Milbouw G; Hermanne JP; Schijns VE; Chen TC
    Vaccine; 2008 Mar; 26(14):1764-72. PubMed ID: 18336964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of vimentin and glial fibrillary acidic protein in ethylnitrosourea-induced rat gliomas and glioma cell lines.
    Reifenberger G; Bilzer T; Seitz RJ; Wechsler W
    Acta Neuropathol; 1989; 78(3):270-82. PubMed ID: 2475009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of human glioma-associated antigen by rat monoclonal antibody raised against syngeneic rat glioma cells.
    Saya H; Masuko T; Kokunai T; Yagita H; Ijichi A; Taomoto K; Tamaki N; Matsumoto S; Hashimoto Y
    J Neurosurg; 1986 Oct; 65(4):495-502. PubMed ID: 3760959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitrosourea-induced brain tumors: an in vivo and in vitro tumor model system.
    Yoshida J; Cravioto H
    J Natl Cancer Inst; 1978 Aug; 61(2):365-74. PubMed ID: 277724
    [No Abstract]   [Full Text] [Related]  

  • 19. Glioma-specific cytotoxic T cells can be effectively induced by subcutaneous vaccination of irradiated wild-type tumor cells without artificial cytokine production.
    Iwadate Y; Yamaura A; Sakiyama S; Sato Y; Tagawa M
    Int J Oncol; 2003 Aug; 23(2):483-8. PubMed ID: 12851699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous serologic responses in glioma patients. Correlation with tumor grade and survival.
    Kornblith PL; Coakham HB; Pollock LA; Wood WC; Green SB; Smith BH
    Cancer; 1983 Dec; 52(12):2230-5. PubMed ID: 6640493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.